110 related articles for article (PubMed ID: 10741140)
21. Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.
Salaverria I; Beà S; Lopez-Guillermo A; Lespinet V; Pinyol M; Burkhardt B; Lamant L; Zettl A; Horsman D; Gascoyne R; Ott G; Siebert R; Delsol G; Campo E
Br J Haematol; 2008 Mar; 140(5):516-26. PubMed ID: 18275429
[TBL] [Abstract][Full Text] [Related]
22. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.
Shiota M; Nakamura S; Ichinohasama R; Abe M; Akagi T; Takeshita M; Mori N; Fujimoto J; Miyauchi J; Mikata A; Nanba K; Takami T; Yamabe H; Takano Y; Izumo T; Nagatani T; Mohri N; Nasu K; Satoh H; Katano H; Fujimoto J; Yamamoto T; Mori S
Blood; 1995 Sep; 86(5):1954-60. PubMed ID: 7655022
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of MUC-1 expression in systemic anaplastic large cell lymphoma.
Rassidakis GZ; Goy A; Medeiros LJ; Jiang Y; Thomaides A; Remache Y; Cabanillas F; Sarris AH; Gilles F
Clin Cancer Res; 2003 Jun; 9(6):2213-20. PubMed ID: 12796388
[TBL] [Abstract][Full Text] [Related]
24. Extra copies of ALK gene locus is a recurrent genetic aberration and favorable prognostic factor in both ALK-positive and ALK-negative anaplastic large cell lymphomas.
Yu R; Chen G; Zhou C; Gao Z; Shi Y; Shi Y; Zhou X; Xie J; Liu H; Gong L
Leuk Res; 2012 Sep; 36(9):1141-6. PubMed ID: 22726922
[TBL] [Abstract][Full Text] [Related]
25. Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas.
Bullrich F; Morris SW; Hummel M; Pileri S; Stein H; Croce CM
Cancer Res; 1994 Jun; 54(11):2873-7. PubMed ID: 8187071
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.
Kadin ME; Pinkus JL; Pinkus GS; Duran IH; Fuller CE; Onciu M; Kawaguchi H; Morris SW
Am J Surg Pathol; 2008 Sep; 32(9):1421-6. PubMed ID: 18670345
[TBL] [Abstract][Full Text] [Related]
27. The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma.
Ladanyi M
Cancer Surv; 1997; 30():59-75. PubMed ID: 9547986
[TBL] [Abstract][Full Text] [Related]
28. The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation.
Kinney MC; Kadin ME
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S56-67. PubMed ID: 9894470
[TBL] [Abstract][Full Text] [Related]
29. Identification of anaplastic lymphoma kinase variant translocations using 5'RACE.
Hernández L; Campo E
Methods Mol Med; 2005; 115():295-314. PubMed ID: 15998975
[TBL] [Abstract][Full Text] [Related]
30. ALK-positive anaplastic large cell lymphoma with leukemic peripheral blood involvement is a clinicopathologic entity with an unfavorable prognosis. Report of three cases and review of the literature.
Onciu M; Behm FG; Raimondi SC; Moore S; Harwood EL; Pui CH; Sandlund JT
Am J Clin Pathol; 2003 Oct; 120(4):617-25. PubMed ID: 14560573
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of the NPM-ALK rearrangement in Hodgkin's disease.
Xerri L; Parc P; Hassoun J; Birnbaum D
J Pathol; 1996 Feb; 178(2):128-32. PubMed ID: 8683377
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of NPM-ALK by siRNA causes anaplastic large cell lymphoma cell growth inhibition and augments the anti cancer effects of chemotherapy in vitro.
Hsu FY; Zhao Y; Anderson WF; Johnston PB
Cancer Invest; 2007 Jun; 25(4):240-8. PubMed ID: 17612934
[TBL] [Abstract][Full Text] [Related]
33. Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study.
Lamant L; McCarthy K; d'Amore E; Klapper W; Nakagawa A; Fraga M; Maldyk J; Simonitsch-Klupp I; Oschlies I; Delsol G; Mauguen A; Brugières L; Le Deley MC
J Clin Oncol; 2011 Dec; 29(35):4669-76. PubMed ID: 22084369
[TBL] [Abstract][Full Text] [Related]
34. Anaplastic large cell lymphoma in leukemic phase: extraordinarily high white blood cell count.
Nguyen JT; Condron MR; Nguyen ND; De J; Medeiros LJ; Padula A
Pathol Int; 2009 May; 59(5):345-53. PubMed ID: 19432678
[TBL] [Abstract][Full Text] [Related]
35. ALK-positive lymphoma: a single disease with a broad spectrum of morphology.
Benharroch D; Meguerian-Bedoyan Z; Lamant L; Amin C; Brugières L; Terrier-Lacombe MJ; Haralambieva E; Pulford K; Pileri S; Morris SW; Mason DY; Delsol G
Blood; 1998 Mar; 91(6):2076-84. PubMed ID: 9490693
[TBL] [Abstract][Full Text] [Related]
36. Detection of t(2;5) in anaplastic large cell lymphoma: comparison of immunohistochemical studies, FISH, and RT-PCR in paraffin-embedded tissue.
Cataldo KA; Jalal SM; Law ME; Ansell SM; Inwards DJ; Fine M; Arber DA; Pulford KA; Strickler JG
Am J Surg Pathol; 1999 Nov; 23(11):1386-92. PubMed ID: 10555007
[TBL] [Abstract][Full Text] [Related]
37. Pediatric ALK+ anaplastic large cell lymphoma with t(3;8)(q26.2;q24) translocation and c-myc rearrangement terminating in a leukemic phase.
Monaco S; Tsao L; Murty VV; Nandula SV; Donovan V; Oesterheld J; Bhagat G; Alobeid B
Am J Hematol; 2007 Jan; 82(1):59-64. PubMed ID: 16955462
[TBL] [Abstract][Full Text] [Related]
38. Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology.
Jaffe ES
Mod Pathol; 2001 Mar; 14(3):219-28. PubMed ID: 11266530
[TBL] [Abstract][Full Text] [Related]
39. Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma?
Fornari A; Piva R; Chiarle R; Novero D; Inghirami G
Hematol Oncol; 2009 Dec; 27(4):161-70. PubMed ID: 19358142
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice.
Lange K; Uckert W; Blankenstein T; Nadrowitz R; Bittner C; Renauld JC; van Snick J; Feller AC; Merz H
Oncogene; 2003 Jan; 22(4):517-27. PubMed ID: 12555065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
